VBP (voluem-based procurement)

The National Drug Alliance Procurement Office, which oversees the Volume-Based Procurement (VBP) program, has issued a statement revealing that six pharmaceutical firms were found to have engaged in collusion during the VBP bidding process for bromhexine in the 7th national tender. The implicated companies are Chengdu Xinjie Hi-tech Development Co.,…

The Shaanxi Public Resources Trading Center has announced the formation of a provincial alliance for volume-based procurement (VBP), with Shaanxi taking the lead. The alliance includes participants from Heilongjiang, Anhui, Jiangxi, Henan, Hubei, Hunan, Guangxi, Guizhou, Tibet, Qinghai, Ningxia, and Xinjiang, along with the Xinjiang Construction Corps. The alliance’s tender…

The National Drug Alliance Procurement Office in China has published the winning results of the continued tender for insulin volume-based procurement (VBP), with 14 insulin products securing the available slots. Notably, protamine recombinant human insulin mixed injection (30/70) and insulin detemir, which were part of the previous round, did not…

The National Joint Procurement Office in China has released a notification outlining the information and filing requirements for the continuation of insulin drug procurement contracts under the volume-based procurement (VBP) program. The renewal process for these insulin VBP contracts is set to commence from March 15, 2024. The inaugural national-level…

The National Healthcare Security Administration (NHSA) has issued a notification outlining key measures to ensure the supply security of volume-based procurement (VBP) winning bids. The strategies aim to maintain the stability and reliability of medical product supplies within the country’s healthcare system. The measures include the timely organization of procurement…

The National Allied Procurement Office has released a notification outlining plans for a volume-based procurement (VBP) tender, focusing on artificial lenses and sports medicine medical consumables, with an encouragement for products utilizing additive manufacturing technology, namely 3D printing, to participate. Scope of the TenderThe tender’s scope encompasses a range of…

The results of the 9th round of China’s national volume-based procurement (VBP) program have been announced, with a total of 175 drug manufacturers securing tender spots for 41 different drug products. The tender for levonorgestrel did not yield successful bids. Out of the 269 separate tender spots secured, only 5…

The National Allied Procurement Office has released a notification regarding Round 9 of the national Volume-Based Procurement (VBP) tender program. This year introduces a novelty where all drugs with marketing approvals before October 30, 2023, are eligible to apply for inclusion in the VBP tender before November 2, provided their…

The national drug alliance procurement office has issued a notification detailing the tendering rules for the 9th national Volume-Based Procurement (VBP) round, along with the finalized drug list. This round involves a total of 42 drugs, spanning 12 treatment areas and representing a market value of RMB 10.963 billion (USD…

The Beijing Municipal Medical Insurance Bureau has announced its participation in the Jiangxi-led interferon inter-provincial alliance volume-based procurement (VBP) tender. Medical institutions are required to submit their demand volumes from September 27 to October 16. The tender includes a total of 15 drug varieties across 95 different specifications, shortlisted from…

The Guangdong Medicine Exchange has issued three notifications regarding the volume-based procurement (VBP) of medical device products. This initiative will focus on tenders for nerve intervention spring coils, liver function biochemical testing reagents, and joint bone cement medical consumables. Guangdong is taking the lead in the “3+N” alliance, which includes…

Shanghai’s healthcare security administration has announced a comprehensive set of measures aimed at enhancing community healthcare service capabilities. These initiatives include an appropriate increase in the outpatient and emergency clinic reimbursement ratio in primary medical institutions, aligning with the city’s commitment to improving access to healthcare services for its residents.…

The Beijing Municipal Medical Insurance Bureau has issued a notification to commence the drug volume-based procurement (VBP) for the Beijing-Tianjin-Hebei region, covering a total of 37 drugs, including biological agents such as coagulation factors, fibrinogen, and human serum albumin. This initiative aims to streamline drug procurement processes and ensure cost-effective…

The National Allied Procurement Office has released a notification initiating the information filing process for drugs selected for the 9th national volume-based procurement (VBP) tender round. A total of 44 chemical drugs across 195 different specifications have been selected, with hospitals required to provide details of volume-usage for the affected…